1. Home
  2. NEOG vs XNCR Comparison

NEOG vs XNCR Comparison

Compare NEOG & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$12.30

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$23.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
XNCR
Founded
1981
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
NEOG
XNCR
Price
$12.30
$23.51
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$10.67
$22.33
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
04-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
99.20
65.36
EPS
N/A
N/A
Revenue
$870,400,000.00
$125,576,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.65
52 Week Low
$4.90
$8.49
52 Week High
$12.85
$30.61

Technical Indicators

Market Signals
Indicator
NEOG
XNCR
Relative Strength Index (RSI) 59.34 49.04
Support Level $11.37 $11.20
Resistance Level $12.26 $30.61
Average True Range (ATR) 0.38 1.45
MACD -0.05 -0.70
Stochastic Oscillator 58.59 9.93

Price Performance

Historical Comparison
NEOG
XNCR

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: